Europe COVID-19 tracker - HSBC Global Research
←
→
Page content transcription
If your browser does not render page correctly, please read the page content below
13 October 2021 Europe COVID-19 tracker Free to View Economics - Europe Turning points? With COVID-19 remaining under control, the surge in energy Fabio Balboni prices continues to dominate the headlines… Senior Economist HSBC Bank plc …with markets now pricing in the first ECB rate rise by 2022 Meanwhile, supply constraints are starting to have a bearing on the recovery, and countries are looking at ways to tackle them Preparing for the winter The COVID-19 situation remains under control across the continent, but there are signs of a renewed deterioration in the UK. Countries are focussing on limiting the risks heading into the winter months and reinvigorating the vaccination campaigns which are slowing (charts 1-9). The Italian government confirmed that from 15 October, a COVID-19 ‘green- passport’ will be required for all public and private sector jobs. Per the press, with 2.5m unvaccinated workers, this could pose huge challenges and require up to 15m tests per week (Il Sole 24 Ore, 12 October). In Germany, booster shots of mRNA vaccines have now been officially recommended for all people above the age of 70 and at higher risk. Energy concerns continue to dominate Surging energy prices continue to dominate the headlines across Europe. In an extreme scenario, we estimate this could push inflation towards 5% y-o-y in Q4. The actual peak might be lower, as many countries announced interventions to cap price rises for the consumers. On 13 October, the European Commission (EC) unveiled a ‘toolkit’ of extra measures which countries can use, ranging from tax cuts, support to hard-hit industries without violating the EU’s state aid rules, and diverting revenue from the EU Emission Trading Scheme to help poorer households. Nuclear power is also on the agenda, with French president Emmanuel Macron expected to give the go-ahead for a cluster of nuclear reactors (FT, 12 October) and pushing, alongside the Czech Republic and Finland, for the EC to designate nuclear power as a “green” technology under the upcoming taxonomy. As inflation rises, markets are also warming up to the idea of a hawkish turn by the ECB (charts 28-33). The first rate hike is now fully priced in by the end of 2022. ECB Chief Economist Philip Lane, though, re-stated that the energy shock should not “have much of footprint on the medium-term inflation outlook” (Reuters, 11 October). Supply constraints biting, budget season continues Supply chain disruptions are holding back the manufacturing sector, with output dropping 1.6% m-o-m in August in the eurozone, led by a huge 17.2% m-om fall in car production (charts 16-21). Labour shortages are also becoming more widespread (charts 22-27). Meanwhile, the 2022 budget announcements continue to trickle in. Spain confirmed the tendency seen in France and Italy, maintaining an expansionary fiscal policy stance. On 12 October, Mr Macron announced a new EUR30bn plan to support high-tech industries and reduce dependence on imports, comprising EUR3-4bn of extra spending already in 2022. Tables 49-54 have been updated to reflect the latest fiscal announcements for 2022. This is an abridged version of a report by the same title published on 13-Oct-21. Please contact your HSBC representative or email AskResearch@hsbc.com for more information. Disclosures & Disclaimer Issuer of report: HSBC Bank plc This report must be read with the disclosures and the analyst certifications in View HSBC Global Research at: the Disclosure appendix, and with the Disclaimer, which forms part of it. https://www.research.hsbc.com
Free to View ● Economics - Europe 13 October 2021 Signs of deterioration in the UK COVID-19 situation 1. New cases in the eurozone Big 4 stay low but they are back on the rise in the UK 000s COVID-19 cases* in the eurozone 'big 4' and UK 000s 160 160 Thousands Thousands 140 140 120 120 100 100 80 80 60 60 40 40 20 20 0 0 Feb-20 Apr-20 Jun-20 Aug-20 Oct-20 Dec-20 Feb-21 Apr-21 Jun-21 Aug-21 Oct-21 Germany France Italy Spain UK Source: Refinitiv Datastream, HSBC. Note: *7-day moving average. 2. The UK, Ireland, the Netherlands and to a lesser extent Greece saw more cases last week 7dma Daily COVID-19 cases per 100k of population 7dma 60 60 50 50 40 40 30 30 20 20 10 10 0 0 Spain Germany Portugal Sweden Italy Ireland Greece Netherlands Belgium Norway UK France Switzerland 7-days to 5-Oct 7-days to 12-Oct Source: Refinitiv Datastream, HSBC. Note: Weekend numbers are reported as 0 so “7-days to” does not include Saturday and Sunday. 3. ICU numbers continue to ease although 4. …and new deaths remain low compared hospital admissions are rising in the UK… with previous waves Total COVID-19 related ICU patients (7 dma) Total No. COVID-19 related deaths (7 dma) No. 8000 8000 1400 1400 1200 1200 6000 6000 1000 1000 800 800 4000 4000 600 600 2000 2000 400 400 200 200 0 0 0 0 Mar-20 Jul-20 Nov-20 Mar-21 Jul-21 Feb-20 Jul-20 Dec-20 May-21 Oct-21 Germany France Italy Germany France Italy Spain UK* UK Spain Source: Macrobond, HSBC. Note: *medically ventilated. Source: Our World in Data, HSBC. We acknowledge the assistance of Yash Dewan, HSBC Bank plc, in the preparation of this report. 2
Free to View ● Economics - Europe 13 October 2021 Increasing vaccine coverage remains the priority 5. Vaccine coverage is high in most western European countries… Number Number of v accine doses administered per 100 people Number 180 180 150 150 120 120 90 90 60 60 30 30 0 0 Spain (10 Oct) Poland (4 Oct) Malta (10 Oct) Sweden (8 Oct) Denmark (10 Oct) Portugal (4 Oct) Norway (10 Oct) Greece (11 Oct) Finland (10 Oct) Romania (10 Oct) Germany (11 Oct) UK (10 Oct) Ireland (5 Oct) Bulgaria (11 Oct) Italy (11 Oct) US (9 Oct) France (10 Oct) Source: Our World in Data, HSBC. 6. … but countries are struggling to avert the 7. Germany has now provided just over a downward trend in vaccination rates million booster shots No. Daily COVID-19 v accine doses No. 000s Germany : Vaccination by type (weekly avg.) 000s 14000 14000 600 600 Thousands 12000 12000 500 500 10000 10000 400 400 8000 8000 6000 6000 300 300 4000 4000 200 200 2000 2000 100 100 0 0 Dec-20 Mar-21 Jun-21 Sep-21 0 0 Germany France Italy Dec-20 Feb-21 Apr-21 May-21 Jul-21 Aug-21 Spain UK US First dose Second dose Booster Source: Our World in Data, HSBC. Source: Macrobond, HSBC. 8. The number of cases among children 9. …but remains relatively contained in other and young continues to rise in the UK… countries such as France 000s England: New COVID cases by age (7 dma) 000s 000s France: New COVID-19 cases by age (7 dma) 000s 25 25 16 16 Thousands Thousands 14 14 20 20 12 12 15 15 10 10 8 8 10 10 6 6 4 4 5 5 2 2 0 0 0 0 Mar-20 Jul-20 Nov-20 Mar-21 Jul-21 Jun-20 Sep-20 Dec-20 Mar-21 Jun-21 Sep-21 0-4 5-14 15-34 0-9 10-19 20-39 35-59 60-79 80< 49-59 60-79 80< Source: UK government, HSBC Source: France government, HSBC 3
Free to View ● Economics - Europe 13 October 2021 The peak of the re-opening process is now behind us 10. UK retail mobility continues to soften 11. …and a similar trajectory is seen in the after the end of the summer… eurozone with limited restrictions back Index UK: Stringency of restrictions Dev iation Index Eurozone: Stringency of restrictions Dev iation and retail mobility from baseline and retail mobility from baseline 0 20 0 20 20 0 20 0 40 -20 40 -20 60 -40 60 -40 80 -60 80 -60 100 -80 100 -80 Feb-20 Jun-20 Oct-20 Feb-21 Jun-21 Oct-21 Feb-20 Jun-20 Oct-20 Feb-21 Jun-21 Oct-21 Stringency score (LHS, inverted) Mobility (RHS) Stringency score (LHS, inverted) Mobility (RHS) Source: Google mobility, Oxford COVID-19 Government response Tracker, HSBC. Source: Google mobility, Oxford COVID-19 Government response Tracker, HSBC 12. Retail mobility is now close to pre-pandemic levels in most European countries although on a slight downward trajectory… % from baseline Europe and US: Mobility data - retail and recreation* % from baseline 20 20 0 0 -20 -20 -40 -40 -60 -60 -80 -80 -100 -100 Mar-20 May-20 Jul-20 Sep-20 Nov-20 Jan-21 Mar-21 May-21 Jul-21 Sep-21 Nov-21 Germany France Italy Spain UK Sweden Norway US Source: Google, HSBC. Note: *7-day moving average. 13. …while workplace mobility is on a slight upward trajectory but remains below pre-crisis levels as more people are choosing to work remotely % from baseline Europe and US: Mobility data - w orkplaces* % from baseline 20 20 0 0 -20 -20 -40 -40 -60 -60 -80 -80 Mar-20 May-20 Jul-20 Sep-20 Nov-20 Jan-21 Mar-21 May-21 Jul-21 Sep-21 Nov-21 Germany France Italy Spain UK Sweden Norway US Source: Google, HSBC. Note: *7-day moving average. 4
Free to View ● Economics - Europe 13 October 2021 All quiet on the restrictions front 14. Latest on the restrictions from the major European countries Country Latest lockdown measures Germany German nationwide COVID-19 policies are currently based on the Infection Protection Act amended on 23 August which states that restrictions and regulations are subject to first, the new infection numbers, second, the ICU capacity usage as well as the increase in ICU numbers and third, the vaccination progress. In general, the current regulation still strictly limits the general accesses to public and private indoor events like restaurants, (sporting) events, personal services, general accommodation and visiting public institutions (in particular care homes and hospitals). People are exempt from this restriction as long as they can provide either a negative test result on COVID-19 or are either fully vaccinated or have recovered from COVID-19. However, German federal states can relax this so called 3G-rule so that in practice only very few restrictions remain. These include the general obligation to wear masks indoors as well as e.g. on public transport. Additionally, some federal states have even further relaxed rules for businesses and accommodation services if they limit access to only fully vaccinated and recovered people (2G-rule), In this case they are allowed to lift e.g. the mask wearing obligation or increase the allowed customer capacity. France Currently, only some overseas territories are under local lockdowns or curfews. In metropolitan France, current restrictions are focused on unvaccinated people (aged above 12) via the imposition of a COVID-19 health pass (i.e. a proof of vaccination or a negative test) called ‘passe sanitaire’ to access some activities (museums, cinemas, bars, restaurants, large shopping malls, hospitals and some long-distance transports like airplanes and trains). COVID-19 tests will no longer be free of charge for unvaccinated adults from 15 October. In addition, vaccination is mandatory for some key occupations (healthcare, firemen) and breaches can lead to penalties like suspension without pay. Primary, secondary and high schools re-opened on 2 September with 100% of physical attendance but will maintain strict protocols (frequent testing, mask wearing, limitation of interactions) for the departments where incidence rate is high. In primary schools, the detection of one COVID-19 case in a classroom will lead to its closure for 7 days (with lessons being held on distance). For secondary and high schools, in the same situation, vaccinated pupils will be authorised to continue to attend lessons physically. Spain On 9 May, the state of emergency expired and was not extended by the government. With that, the nationwide curfew also came to an end, even though it remains in place in some cities in Andalusia (2-7am), Catalonia, Valencia Community, and Navarra (1-6am) while some regions still impose limited restrictions to nightlife. The freedom to travel across regions has been re-established, with no regions maintaining the external border closure in place. From 6 June, Masks are no longer necessary in outdoor settings where social distancing is observed. Most regions still impose limitations in terms of the maximum number of people allowed for gatherings. Some regions have introduced a ‘green pass’ requirement for entering cultural and sports events, and some are considering also for restaurants and bars. Spain’s external frontier remains open. For entry, a proof of vaccination or a negative COVID-19 test is required. Italy Currently, all the Italian territory is in the ‘white’ category with hardly any restrictions (other than obligatory mask wearing indoors – since 28 June, masks are no longer required outdoors – and some social distancing requirements). The government has introduced a ‘green pass’ requirement (full vaccination or negative COVID-19 test) to go into restaurants and bars (indoors), theatres, cinemas public transport, as well as some outdoors venues, and attend concerts and sporting events. The government has recently announced that from 15 October until the end of the year the ‘green pass’ will be required for all public and private sector workers, with high penalties for the non-compliant. As for international travel, people arriving from the EU no longer have to quarantine, but they will be required to show a negative COVID-19 test undertaken within 48 hours before departure (unless fully vaccinated). For the UK, the government introduced a special 5-day quarantine requirement (fully vaccinated people, though, are exempt). UK Having been in lockdown through the first quarter of the year, the UK economy has now largely re-opened. In September, the English government said it would not be going ahead with plans for a ‘vaccine passport’ to enter nightclubs, meaning there are essentially no restrictions on social contact or economic activity, though it warned that it might have to reintroduce mask wearing and the recommendation to work from home, if the COVID-19 situation worsened. For Scotland, Wales and Northern Ireland, mask wearing remains mandatory, and the former two have ‘vaccine passport’ systems in place for nightclubs and some other venues. New travel rules were announced on 17 September, which divides arrivals into two groups – ‘red list’ and the rest of the world. Under the new system, entry into the UK from the red list remains banned to non-UK or Irish nationals. As of 15 February, for those who cannot be refused entry from these countries – i.e. returning British or Irish nationals – a mandatory 10-day quarantine in government-approved accommodation applies. But the number of countries on the list was slashed in October, from over 50 to just seven. For those arriving into England and Scotland from the rest of the world, no pre-departure tests are required, and only a lateral flow test, rather than a PCR, will be required, on day 2 after arrival. Wales and Northern Ireland are considering whether to drop the PCR requirement. Source: Country data, HSBC 5
Free to View ● Economics - Europe 13 October 2021 Rising inflationary pressures due to surging energy prices 16. Eurozone industrial production fell 17. The main culprit was faltering car sharply in August with Germany faring worst production due to supply constraints Index (100 = Eurozone: Industrial production Index (100 = Index Eurozone: Industrial production Index Jan 20) Jan 20) (Jan 20 = 100) (Jan 20 = 100) 110 110 120 120 100 100 100 100 90 90 80 80 80 80 60 60 70 70 40 40 20 20 60 60 0 0 50 50 2019 2020 2021 Jan-19 Jul-19 Jan-20 Jul-20 Jan-21 Jul-21 Industrial production IP ex. motor vehicles Eurozone Germany France IP motor vehicles Italy Spain Source: Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, HSBC. 18. The gap between orders and productions 19. The ZEW saw another sharp drop in in Germany remains high, even if new orders expectations while also current conditions are now also plunged 7.7% in August now appear to be past the peak Index Germany : Orders and production Index Index Germany : ZEW survey Index (Jan 20 = 100) (Jan 20 = 100) 100 100 125 125 75 75 100 100 50 50 75 75 25 25 50 50 0 0 25 25 -25 -25 0 0 -50 -50 -25 -25 -75 -75 2010 2012 2014 2016 2018 2020 -100 -100 Gap 2010 2012 2014 2016 2018 2020 New manufacturing orders IP (ex. energy and constr.) ZEW expectations ZEW current situation Source: Macrobond, HSBC. Source: Macrobond, HSBC. 20. The ZEW survey saw sentiment falling 21. German trade data also show the across all sector, and particularly in export sector has been losing momentum mechanical engineering and car production Index Germany : ZEW sector breakdown Index EURbn Germany : Trade balance % m-o-m 100 100 75 75 25 25 50 50 15 15 25 25 5 5 0 0 -25 -25 -5 -5 -50 -50 -15 -15 -75 -75 -100 -100 -25 -25 2015 2016 2017 2018 2019 2020 2021 2019 2020 2021 Mechanical eng. IT Trade balance (LHS) Exports (RHS) Imports (RHS) Construction Automobile Source: Macrobond, HSBC Source: Refinitiv Datastream, HSBC 6
Free to View ● Economics - Europe 13 October 2021 Labour shortages becoming more and more evident 22. Labour shortages are higher than before 23. After the re-opening, also the services the crisis in manufacturing in the eurozone sector is starting to see labour shortages Index EC manufacturing survey: Factors limiting Index Index EC serv ices survey: Factors limiting Index production - labour business - labour 30 30 35 35 25 25 30 30 20 20 25 25 20 20 15 15 15 15 10 10 10 10 5 5 5 5 0 0 0 0 2010 2012 2014 2016 2018 2020 2010 2012 2014 2016 2018 2020 Eurozone Germany France Eurozone Germany France Italy Spain Italy Spain Source: European Commission. Source: European Commission. 24. In France, the share of firms facing 25. ...and in Italy labour shortages are now hiring difficulties is increasing rapidly… more acute than before the crisis % France: Share of firms facing difficulties of hiring % % Italy : Vacancy rate and obstacles to production % 90 90 4.0 4.0 75 75 3.5 3.5 3.0 3.0 60 60 2.5 2.5 45 45 2.0 2.0 30 30 1.5 1.5 1.0 1.0 15 15 0.5 0.5 0 0 0.0 0.0 2005 2008 2011 2014 2017 2020 Sep-18 Mar-19 Sep-19 Mar-20 Sep-20 Mar-21 Manufacturing Services Building Labour shortages Vacancy rate Source: INSEE, HSBC. Source: ISTAT, Eurostat. 26. Italian firms see higher costs and longer 27. In the UK, the labour market remains hot delivery times as major obstacles to their with increasing evidence of labour ability to export shortages putting pressure on wages % Italy : Main obstacles to ex ports % Index UK: REC/KPMG job surveys Index 25 25 90 90 20 20 70 70 15 15 50 50 10 10 30 30 5 5 10 10 0 0 2018 2019 2020 2021 2013 2014 2015 2016 2017 2018 2019 2020 2021 Overall staff availability Permanent staff salaries Higher costs/prices Longer delivery times Index of demand for staff Source: ISTAT. Source: REC, KPMG. 7
Free to View ● Economics - Europe 13 October 2021 Inflation concerns building 28. Wholesale gas and energy prices 29. …compounded by rising oil prices continue to soar… which is now feeding through pump prices EUR Netherlands: Energy prices EUR EUR/litre Eurozone: Petrol pump prices EUR/bbl per MWh per MWh and Brent crude 210 350 1700 75 180 300 1600 65 150 250 1500 55 120 200 90 150 1400 45 60 100 1300 35 30 50 1200 25 0 0 1100 15 2010 2012 2014 2016 2018 2020 Jan-19 Jul-19 Jan-20 Jul-20 Jan-21 Jul-21 Gas prices - 1-month future (LHS) Pump prices (LHS) Oil price (RHS) Electricity prices - 1-month future (RHS) Source: Bloomberg, Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, European Commission, HSBC. 30. We estimate this could push inflation 31. The market has now fully priced in the towards 5% y-o-y in an extreme scenario first ECB rate increase by the end of 2022 % Yr ECB forecast: HICP inflation % Yr % EUR OIS forw ards % 5 5 0.3 0.3 0.2 0.2 4 4 0.1 0.1 3 3 0.0 0.0 -0.1 -0.1 2 2 -0.2 -0.2 1 1 -0.3 -0.3 -0.4 -0.4 0 0 -0.5 -0.5 2021 2022 2023 -0.6 -0.6 Sep 21 ECB f'cast HSBC (latest) 2021 2022 2023 2024 2025 2026 Full pass-through Full P-T (temp.) 13-Oct 10-Sep 30-Jul 14-May Source: ECB, HSBC Source: Bloomberg. 32. The rise in the 5yr-5yr inflation swaps 33. ...and medium-term inflation seems to have stalled though... expectations in the ZEW survey continued to decline in October % Eurozone: 5Yr 5Yr inflation sw aps % Index ZEW inflation ex pectations Index 2.0 2.0 100 100 75 75 50 50 1.5 1.5 25 25 0 0 1.0 1.0 -25 -25 -50 -50 0.5 0.5 2015 2016 2017 2018 2019 2020 2021 2016 2017 2018 2019 2020 2021 Eurozone Germany Source: Bloomberg. Source: Macrobond, HSBC. 8
Free to View ● Economics - Europe 13 October 2021 COVID-19 in Western Europe 34. New infection numbers have recently 35. The latest COVID-19 wave seems to been steady in Germany have been well contained in France… 000s. Germany : COVID-19 cases 000s. 000s. France: COVID-19 cases 000s. 4500 35 7000 105 Thousands Thousands 6000 90 3600 28 5000 75 2700 21 4000 60 1800 14 3000 45 2000 30 900 7 1000 15 0 0 0 0 Jan-20 Jun-20 Nov-20 Apr-21 Sep-21 Jan-20 Jun-20 Nov-20 Apr-21 Sep-21 New cases (RHS) Cumulative (LHS) New cases (RHS) Cumulative (LHS) Source: Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, HSBC. 36. …and in Italy, also thanks to a tough 37. Solid progress in Spain’s vaccination application of the COVID-19 ‘green-pass’ programme seems to be paying off 000s. Italy : COVID-19 cases 000s. 000s. Spain: COVID-19 cases 000s. 5000 45 5200 100 Thousands Thousands 4000 36 3900 75 3000 27 2600 50 2000 18 1300 25 1000 9 0 0 0 0 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 Jan-20 Jun-20 Nov-20 Apr-21 Sep-21 New cases (RHS) Cumulative (LHS) New cases (RHS) Cumulative (LHS) Source: Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, HSBC. 38. UK numbers are still high compared with 39. The fourth wave of COVID-19 seems to the rest of Europe and now back on the rise have been contained in Switzerland 000s. UK: COVID-19 cases 000s. 000s. Sw itzerland: COVID-19 cases 000s. 9000 90 900 24 Thousands Thousands 7500 75 750 20 6000 60 600 16 4500 45 450 12 3000 30 300 8 1500 15 150 4 0 0 0 0 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 New cases (RHS) Cumulative (LHS) New cases (RHS) Cumulative (LHS) Source: Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, HSBC. 9
Free to View ● Economics - Europe 13 October 2021 40. Case numbers remain fairly elevated in 41. Norway seems to have brought the Belgium and are rising in the Netherlands latest COVID-19 wave under control 000s. Netherlands/Belgium : COVID-19 cases 000s. 000s. Norw ay: COVID-19 cases 000s. 2400 28 200 5 Thousands Thousands 1800 21 160 4 120 3 1200 14 80 2 600 7 40 1 0 0 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 0 0 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 NL - New cases (RHS) BE - New cases (RHS) New cases (RHS) Cumulative (LHS) NL - Cumulativ e (LHS) BE - Cumulative (LHS) Source: Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, HSBC. 42. Swedish case numbers remain low 43. In Ireland, there are some early sighs despite re-openings and the colder weather of a possible new wave of infections 000s. Sw eden: COVID-19 cases 000s. 000s. Ireland: COVID-19 cases 000s. 1200 12 400 10 Thousands Thousands 900 9 320 8 240 6 600 6 160 4 300 3 80 2 0 0 0 0 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 New cases (RHS) Cumulative (LHS) New cases (RHS) Cumulative (LHS) Source: Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, HSBC. 44. In Portugal, the Delta wave seems to 45. …but less so in Greece, where have been contained… infections rates remain relatively high 000s. Portugal: COVID-19 cases 000s. 000s. Greece: COVID-19 cases 000s. 1200 18 720 6 Thousands Thousands 15 600 5 900 12 480 4 600 9 360 3 6 240 2 300 3 120 1 0 0 0 0 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 Jan-20 May-20 Sep-20 Jan-21 May-21 Sep-21 New cases (RHS) Cumulative (LHS) New cases (RHS) Cumulative (LHS) Source: Refinitiv Datastream, HSBC. Source: Refinitiv Datastream, HSBC. 10
Free to View ● Economics - Europe 13 October 2021 Fiscal measures (in the Big 4 eurozone countries and the UK) 46. Fiscal policy was highly supportive of growth last year even if a significant chunk of support did not make it into the economy due to restrictions and was actually saved % GDP Fiscal impulse: Decomposition of deficit changes in 2020 % GDP 8 8 7 7 6 6 5 5 4 4 3 3 2 2 1 1 0 0 Eurozone Germany France Italy Spain* Discretionary One-offs Economic cycle Fiscal impulse Deficit change Source: HSBC calculations based on national statistical institutes, Eurostat and European Commission, 2020 budgets and amendments. Notes: * Discounting the impact (0.9% of GDP) of the incorporation of ‘Sareb’ under the public sector. The ‘Economic Cycle’ component for eurozone countries and the Big 4 includes the ‘normal’ short-time work compensation schemes but not the extensions and more generous terms agreed in response to the COVID-19 crisis.. 47. Stronger-than-anticipated growth has helped contain the fiscal deficits this year despite fiscal policy remaining expansionary % GDP Fiscal impulse: Decomposition of deficit changes in 2021 % GDP 5 5 4 4 3 3 2 2 1 1 0 0 -1 -1 -2 -2 -3 -3 Eurozone Germany France Italy Spain Discretionary Economic cycle NGEU 'grants' 2020 One-offs expiring Fiscal impulse Deficit change Source: HSBC calculations based on national statistical institutes, Eurostat and European Commission, 2020 budgets and amendments. Notes: The ‘Economic Cycle’ component for eurozone countries and the Big 4 includes the ‘normal’ short-time work compensation schemes but not the extensions and more generous terms agreed in response to the COVID-19 crisis. 48. In 2022, the domestic fiscal policy stance should turn broadly neutral with the bulk of expansion across the eurozone provided by the Next Generation EU (NGEU) fund % GDP Fiscal impulse: Decomposition of deficit changes in 2022 % GDP 4 4 3 3 2 2 1 1 0 0 -1 -1 -2 -2 -3 -3 -4 -4 -5 -5 Eurozone Germany France Italy Spain Discretionary Economic cycle NGEU 'grants' 2020 One-offs expiring Fiscal impulse Deficit change Source: HSBC calculations based on national statistical institutes, Eurostat and European Commission, 2020 budgets and amendments. Notes: The adjusted series takes into account that due to ongoing restrictions at least part of the stimulus implemented last year and this year did not actually feed through into the economy but will only do so once restrictions are lifted. 11
Free to View ● Economics - Europe 13 October 2021 Disclosure appendix Analyst Certification The following analyst(s), economist(s), or strategist(s) who is(are) primarily responsible for this report, including any analyst(s) whose name(s) appear(s) as author of an individual section or sections of the report and any analyst(s) named as the covering analyst(s) of a subsidiary company in a sum-of-the-parts valuation certifies(y) that the opinion(s) on the subject security(ies) or issuer(s), any views or forecasts expressed in the section(s) of which such individual(s) is(are) named as author(s), and any other views or forecasts expressed herein, including any views expressed on the back page of the research report, accurately reflect their personal view(s) and that no part of their compensation was, is or will be directly or indirectly related to the specific recommendation(s) or views contained in this research report: Fabio Balboni Important disclosures This document has been prepared and is being distributed by the Research Department of HSBC and is not for publication to other persons, whether through the press or by other means. This document is for information purposes only and it should not be regarded as an offer to sell or as a solicitation of an offer to buy the securities or other investment products mentioned in it and/or to participate in any trading strategy. Advice in this document is general and should not be construed as personal advice, given it has been prepared without taking account of the objectives, financial situation or needs of any particular investor. Accordingly, investors should, before acting on the advice, consider the appropriateness of the advice, having regard to their objectives, financial situation and needs. If necessary, seek professional investment and tax advice. Certain investment products mentioned in this document may not be eligible for sale in some states or countries, and they may not be suitable for all types of investors. Investors should consult with their HSBC representative regarding the suitability of the investment products mentioned in this document and take into account their specific investment objectives, financial situation or particular needs before making a commitment to purchase investment products. The value of and the income produced by the investment products mentioned in this document may fluctuate, so that an investor may get back less than originally invested. Certain high-volatility investments can be subject to sudden and large falls in value that could equal or exceed the amount invested. Value and income from investment products may be adversely affected by exchange rates, interest rates, or other factors. Past performance of a particular investment product is not indicative of future results. HSBC and its affiliates will from time to time sell to and buy from customers the securities/instruments, both equity and debt (including derivatives) of companies covered in HSBC Research on a principal or agency basis or act as a market maker or liquidity provider in the securities/instruments mentioned in this report. Analysts, economists, and strategists are paid in part by reference to the profitability of HSBC which includes investment banking, sales & trading, and principal trading revenues. Whether, or in what time frame, an update of this analysis will be published is not determined in advance. For disclosures in respect of any company mentioned in this report, please see the most recently published report on that company available at www.hsbcnet.com/research. HSBC Private Banking clients should contact their Relationship Manager for queries regarding other research reports. In order to find out more about the proprietary models used to produce this report, please contact the authoring analyst. Additional disclosures 1 This report is dated as at 13 October 2021. 2 All market data included in this report are dated as at close 12 October 2021, unless a different date and/or a specific time of day is indicated in the report. 3 HSBC has procedures in place to identify and manage any potential conflicts of interest that arise in connection with its Research business. HSBC’s analysts and its other staff who are involved in the preparation and dissemination of Research operate and have a management reporting line independent of HSBC’s Investment Banking business. Information Barrier procedures are in place between the Investment Banking, Principal Trading, and Research businesses to ensure that any confidential and/or price sensitive information is handled in an appropriate manner. 4 You are not permitted to use, for reference, any data in this document for the purpose of (i) determining the interest payable, or other sums due, under loan agreements or under other financial contracts or instruments, (ii) determining the price at which a financial instrument may be bought or sold or traded or redeemed, or the value of a financial instrument, and/or (iii) measuring the performance of a financial instrument or of an investment fund. 12
Free to View ● Economics - Europe 13 October 2021 Disclaimer Legal entities as at 1 December 2020 Issuer of report ‘UAE’ HSBC Bank Middle East Limited, DIFC; HSBC Bank Middle East Limited, Dubai; ‘HK’ The Hongkong and Shanghai HSBC Bank plc Banking Corporation Limited, Hong Kong; ‘TW’ HSBC Securities (Taiwan) Corporation Limited; ‘CA’ HSBC Securities 8 Canada Square, London (Canada) Inc.; ‘France’ HSBC Continental Europe; ‘Spain’ HSBC Continental Europe, Sucursal en España; ‘Italy’ HSBC E14 5HQ, United Kingdom Continental Europe, Italy; ‘Sweden’ HSBC Continental Europe Bank, Sweden Filial; ‘DE’ HSBC Trinkaus & Burkhardt AG, Telephone: +44 20 7991 8888 Düsseldorf; 000 HSBC Bank (RR), Moscow; ‘IN’ HSBC Securities and Capital Markets (India) Private Limited, Mumbai; ‘JP’ Fax: +44 20 7992 4880 HSBC Securities (Japan) Limited, Tokyo; ‘EG’ HSBC Securities Egypt SAE, Cairo; ‘CN’ HSBC Investment Bank Asia Limited, Website: www.research.hsbc.com Beijing Representative Office; The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch; The Hongkong and Shanghai Banking Corporation Limited, Seoul Securities Branch; The Hongkong and Shanghai Banking Corporation Limited, Seoul Branch; HSBC Securities (South Africa) (Pty) Ltd, Johannesburg; HSBC Bank plc, London, Tel Aviv; ‘US’ HSBC Securities (USA) Inc, New York; HSBC Yatirim Menkul Degerler AS, Istanbul; HSBC México, SA, Institución de Banca Múltiple, Grupo Financiero HSBC; HSBC Bank Australia Limited; HSBC Bank Argentina SA; HSBC Saudi Arabia Limited; The Hongkong and Shanghai Banking Corporation Limited, New Zealand Branch incorporated in Hong Kong SAR; The Hongkong and Shanghai Banking Corporation Limited, Bangkok Branch; PT Bank HSBC Indonesia; HSBC Qianhai Securities Limited; Banco HSBC S.A. In the UK, this publication is distributed by HSBC Bank plc for the information of its Clients (as defined in the Rules of FCA) and those of its affiliates only. Nothing herein excludes or restricts any duty or liability to a customer which HSBC Bank plc has under the Financial Services and Markets Act 2000 or under the Rules of FCA and PRA. A recipient who chooses to deal with any person who is not a representative of HSBC Bank plc in the UK will not enjoy the protections afforded by the UK regulatory regime. HSBC Bank plc is regulated by the Financial Conduct Authority and the Prudential Regulation Authority. If this research is received by a customer of an affiliate of HSBC, its provision to the recipient is subject to the terms of business in place between the recipient and such affiliate. In Australia, this publication has been distributed by The Hongkong and Shanghai Banking Corporation Limited (ABN 65 117 925 970, AFSL 301737) for the general information of its “wholesale” customers (as defined in the Corporations Act 2001). Where distributed to retail customers, this research is distributed by HSBC Bank Australia Limited (ABN 48 006 434 162, AFSL No. 232595). These respective entities make no representations that the products or services mentioned in this document are available to persons in Australia or are necessarily suitable for any particular person or appropriate in accordance with local law. No consideration has been given to the particular investment objectives, financial situation or particular needs of any recipient. In the European Economic Area, this publication has been distributed by HSBC Continental Europe or by such other HSBC affiliate from which the recipient receives relevant services The document is distributed in Hong Kong by The Hongkong and Shanghai Banking Corporation Limited and in Japan by HSBC Securi ties (Japan) Limited. Each of the companies listed above (the “Participating Companies”) is a member of the HSBC Group of Companies, any member of which may trade for its own account as Principal, may have underwritten an issue within the last 36 months or, together with its Directors, officers and employees, may have a long or short position in securities or instruments or in any related instrument mentioned in the document. Brokerage or fees may be earned by the Participating Companies or persons associated with them in respect of any business transacted by them in all or any of the securities or instruments referred to in this document. In Korea, this publication is distributed by either The Hongkong and Shanghai Banking Corporation Limited, Seoul Securities Branch (“HBAP SLS”) or The Hongkong and Shanghai Banking Corporation Limited, Seoul Branch (“HBAP SEL”) for the general information of professional investors specified in Article 9 of the Financial Investment Services and Capital Markets Act (“FSCMA”). This publication is not a prospectus as defined in the FSCMA. It may not be further distributed in whole or in part for any purpose. Both HBAP SLS and HBAP SEL are regulated by the Financial Services Commission and the Financial Supervisory Service of Korea. This publication is distributed in New Zealand by The Hongkong and Shanghai Banking Corporation Limited, New Zealand Branch incorporated in Hong Kong SAR. The information in this document is derived from sources the Participating Companies believe to be reliable but which have not been independently verified. The Participating Companies make no guarantee of its accuracy and completeness and are not responsible for errors of transmission of factual or analytical data, nor shall the Participating Companies be liable for damages arising out of any person’s reliance upon this information. All charts and graphs are from publicly available sources or proprietary data. The opinions in this document constitute the present judgement of the Participating Companies, which is subject to change without notice. From time to time research analysts conduct site visits of covered issuers. HSBC policies prohibit research analysts from accepting payment or reimbursement for travel expenses from the issuer for such visits. This document is neither an offer to sell, purchase or subscribe for any investment nor a solicitation of such an offer. HSBC Securities (USA) Inc. accepts responsibility for the content of this research report prepared by its non-US foreign affiliate. The information contained herein is under no circumstances to be construed as investment advice and is not tailored to the needs of the recipient. All US persons receiving and/or accessing this report and intending to effect transactions in any security discussed herein should do so with HSBC Securities (USA) Inc. in the United States and not with its non-US foreign affiliate, the issuer of this report. In Singapore, this publication is distributed by The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch for the general information of institutional investors or other persons specified in Sections 274 and 304 of the Securities and Futures Act (Chapter 289) (“SFA”) and accredited investors and other persons in accordance with the conditions specified in Sections 275 and 305 of the SFA. Only Economics or Currencies reports are intended for distribution to a person who is not an Accredited Investor, Expert Investor or Institutional Investor as defined in SFA. The Hongkong and Shanghai Banking Corporation Limited, Singapore Branch accepts legal responsibility for the contents of reports pursuant to Regulation 32C(1)(d) of the Financial Advisers Regulations. This publication is not a prospectus as defined in the SFA. This publication is not a prospectus as defined in the SFA. It may not be further distributed in whole or in part for any purpose. The Hongkong and Shanghai Banking Corporation Limited Singapore Branch is regulated by the Monetary Authority of Singapore. Recipients in Singapore should contact a “Hongkong and Shanghai Banking Corporation Limited, Singapore Branch” representative in respect of any matters arising from, or in connection with this report. Please refer to The Hongkong and Shanghai Banking Corporation Limited Singapore Branch’s website at www.business.hsbc.com.sg for contact details. HSBC México, S.A., Institución de Banca Múltiple, Grupo Financiero HSBC is authorized and regulated by Secretaría de Hacienda y Crédito Público and Comisión Nacional Bancaria y de Valores (CNBV). In Canada, this document has been distributed by HSBC Securities (Canada) Inc. (member IIROC), and/or its affiliates. The information contained herein is under no circumstances to be construed as investment advice in any province or territory of Canada and is not tailored to the needs of the recipient. No securities commission or similar regulatory authority in Canada has reviewed or in any way passed judgment upon these materials, the information contained herein or the merits of the securities described herein, and any representation to the contrary is an offense. In Brazil, this document has been distributed by Banco HSBC S.A. (“HSBC Brazil”), and/or its affiliates. As required by Instruction No. 598/18 of the Securities and Exchange Commission of Brazil (Comissão de Valores Mobiliários), potential conflicts of interest concerning (i) HSBC Brazil and/or its affiliates; and (ii) the analyst(s) responsible for authoring this report are stated on the chart above labelled “HSBC & Analyst Disclosures”. The document is intended to be distributed in its entirety. Unless governing law permits otherwise, you must contact a HSBC Group member in your home jurisdiction if you wish to use HSBC Group services in effecting a transaction in any investment mentioned in this document. HSBC Bank plc is registered in England No 14259, is authorised by the Prudential Regulation Authority and regulated by the Financial Conduct Authority and the Prudential Regulation Authority and is a member of the London Stock Exchange. (070905) If you are an HSBC Private Banking (“PB”) customer with approval for receipt of relevant research publications by an applicable HSBC legal entity, you are eligible to receive this publication. To be eligible to receive such publications, you must have agreed to the applicable HSBC entity’s terms and conditions for accessing research and the terms and conditions of any other internet banking service offered by that HSBC entity through which you will access research publications (“the Terms”). Distribution of this publication is the sole responsibility of the HSBC entity with whom you have agreed the Terms. If you do not meet the aforementioned eligibility requirements please disregard this publication and, if you are a customer of PB, please notify your Relationship Manager. Receipt of research publications is strictly subject to the Terms and any other conditions or disclaimers applicable to the provision of the publications that may be advised by PB. © Copyright 2021, HSBC Bank plc, ALL RIGHTS RESERVED. No part of this publication may be reproduced, stored in a retrieval system, or transmitted, on any form or by any means, electronic, mechanical, photocopying, recording, or otherwise, without the prior written permission of HSBC Bank plc. MCI (P) 028/02/2021, MCI (P) 087/10/2020 [1180103] 13
You can also read